Clinical Trials in Arizona

Showing 2781-2800 of 8,032 trials

Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma

NCT02314052

The purpose of this study is to assess the safety and tolerability of the investigational anticancer drug DCR-MYC. DCR-MYC is a novel synthetic double-stranded RNA in a stable lipid particle suspension that targets the oncogene MYC. MYC oncogene activation is important to the growth of many hematologic and solid tumor malignancies. In this study the Sponsor proposes to study DCR-MYC and its ability to inhibit MYC and thereby inhibit cancer cell growth.

Hepatocellular Carcinoma

Dicerna Pharmaceuticals, Inc., a Novo Nordisk company21 participantsStarted Jan 2015

Scottsdale, Arizona, United States • Boston, Massachusetts, United States • San Antonio, Texas, United States +3 more locations

TERMINATEDPhase 349 miles

Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

NCT02914600

The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy discontinuation criteria in a prior filgotinib treatment study in Crohn's disease (CD).

Crohn's Disease

Galapagos NV1,188 participantsStarted Mar 2017

Dothan, Alabama, United States • Sun City, Arizona, United States • Coronado, California, United States +483 more locations

Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma

Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

Find Trials by Condition in Arizona

Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo

A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis

Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization

A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

Vibrant Capsule vs. Placebo for Patient Suffering From Constipation

Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders

Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders

Impact of Microvascular Inflammation on Kidney Allograft Outcome

A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)

A Safety and Effectiveness Study of a New Preservative Free Rewetting Drop

Acute Kidney Injury in Patients Undergoing Contrast Exposure: VQ vs. CT

A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT

C-myc Biomarker Study for Diabetic Foot Ulcers

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia